| Adipose |
Dexamethasone, insulin, methylisobutylxantine, and PPARγ agonist rosiglitazone used to differentiate MSCs Rosiglitazone used independently to differentiate MSCs Decellularized ECM and PCL framework used to differentiate ADSCs |
10, 256
10, 257
258, 259
|
| Bone |
TGF-β superfamily and BMP used to induce differentiation of stem cells toward osteogenic and chondrogenic phenotypes Icroglycerophosphate, insulin, transferrin, selenious acid ,and ascorbate-2-phosphate used to differentiate MSCs to osteogenic phenotype BMP-2 used as bioink additive to induce differentiation of BMSCs MicroRNA sequences miR-23a, miR-30c, MiR-34c, miR-133a, miR-135a, miR-137, miR-204, miR-205, miR-217, miR-218, and miR-338 used to induce osteogenic differentiate through targeting Runx2 transcription factor MicroRNA sequence miRNA-138 used to induce osteogenic differentiation through inhibition of adhesion kinase and signaling cascade HA, and BCPs used to differentiate stem cells in a mouse model PEGDMA supplemented with either HA or bioactive glass used to differentiate MSCs Polylactic acid and polysterene microcarriers used to differentiation MSCs BMP-2 releasing microcarriers used to differentiate goat MSCs |
10, 264, 265
268
269
68, 270
68, 271
10, 165
10, 281
10, 189, 192
10, 137
|
| Cartilage |
BMP-6, EGF, FGF-2, TGF-β1, and other factors used to differentiate ASCs TGF-β1 used to differentiate ASCs TGF-β3, sodium pyruvate, dexamethasone, insulin, transferrin, selenious acid, and ascorbate-2-phosphate used to differentiate MSCs MicroRNA sequence miR-140 used to target IGFBP-5, histone deeylase 4, and Smad3 to cause differentiation MicroRNA sequences miR-199a, miR-18a, miR-221, miR-675, miR-29 and miR-29b used to induce differentiation of stem cells TGF-β1 releasing PLGA microcarriers coated with fibronectin used to differentiate MSCs Nanospheres embedded with TGF-β1 and GelMA supplemented with PEGDA used to differentiate MSCs NR2F2 used to differentiate MSCs Nanofibrillated cellulose with alginate or HA used to differentiate bioprinted human iPSCs |
10, 266
10, 267
268
68, 272-274
68, 275-280
193
282
283
284
|
| Cardiovascular & Cardiomyogenic |
5-AZA used to differentiation human bone marrow MSCs Scaffolds supplemented with alginate and HA/gelatin used to differentiate cardiomyocyte progenitor cells Thiolate HA hydrogels used to differentiate pre-cardiac cells MircoRNA family miR-15 used to promote viability, resistance, and recovery in setting of ischemic injury HA-based synthetic ECM used to promote proliferation and differentiate stem cells Stem cells bioprinted on decellularized ECM to increase viability, proliferation, and differentiation Embryoid bodies used to differentiate ESCs Microchanneled gelatin hydrogel used to differentiate bioprinted human MSCs 4D bioprinting used to optimize surface pattern technology to differentiate MSCs |
10, 286
259, 287, 288
259, 289
68, 290, 291
259, 292
259, 293
259, 294
211
221
|
| Hepatic |
Media supplemented with activing A, Wnt, and KO-DMEM, followed by bioprinting in alginate hydrogel matrix to differentiate human iPSCs Combination of HGF, basic FGF, BMP-4 and patterned printing in a fibronectin and collagen solution used to differentiate ESCs Replication of hexagonal hepatic subunits and bioprinting on gelatin methacrylate and glycidal methacrylate-HA with HUVECs to differentiate ADSCs |
296
259, 297
259, 298
|
| Skeletal Muscle |
BMP-2 and bioprinting in patterned array on fibronectin-coated glass slides used to differentiation MDSCs ECM-like patterned structure supplemented with FGF-2 and BMP-2 used to differentiation C2C12 cells MicroRNA sequences miR-1, miR-27, miR-133, miR-188, and miR-206 used to differentiate stem cells through transcription factors MyoD and MEF2 Topographical alignment of microchannels used to induce MSCs Precise patterned printing to differentiate C2C12 myoblasts Cells printed in alignment instead of random pattern to differentiate C2C12 cells Mimicry of native muscle texture to differentiate bioprinted MDSCs |
259, 153
259, 302
68, 303-306
10, 229
259, 281
259, 308
259, 309
|
| Neural |
Thermoresponsive polyurethane hydrogel bioink used to differentiate NSCs Polysaccharide-based bioink containing alginate, carboxymethyl-chitasan, and agarose used to differentiate printed NSCs Collagen hydrogel supplemented with VEGF used to differentiate mural NSCs Fibronectin-coated PLGA used to differentiate human MSCs FGF-2 and CNTF used to differentiate bioprinted NSCs MicroRNA sequences miR-7, miR-133b, and miR-206 used to promote self-renewal of NSCs, differentiate NSCs and prevent neural degeneration Decreased stiffness in bioprinted matrices used to differentiation MSCs Topographical nanofiber conformations supplemented with retinoic acid loaded PCL nanofibers used to differentiate bioprinted stem cells Bioprinting onto micropatterned PMMA grooved scaffold to differentiate astrocytes |
313
314
10, 136
217, 259
316
68, 317-319
312, 320
10, 279
259, 321
|
| Dermal |
Fibrin-collagen gel used to promote proliferation in bioprinted AFSCs and MSCs Gelatin and fibrin matrix used to differentiate bioprinted MSCs ECM-mimetic created from gelatin and sodium alginate hydrogels to promote regeneration of sweat glands Layered bioprinting and topographical patterning in alginate hydrogel of MSCs, keratinocytes, and fibroblasts to induce microenvironment-mediated tissue formation |
36, 259
259, 323
259, 324
5, 259, 325, 326
|
